Safety Study of a Cell Penetrating Peptide (p28) to Treat Solid Tumors That Resist Standard Methods of Treatment

NCT00914914 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Solid Tumors

Interventions

DRUG: p28

Sponsor

Dr. Tapas K. Das Gupta